Cargando…
Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature
Interferon alfa was first used in the treatment of myeloproliferative neoplasms (MPNs) over 30 years ago. However, its initial use was hampered by its side effect profile and lack of official regulatory approval for MPN treatment. Recently, there has been renewed interest in the use of interferon in...
Autores principales: | How, Joan, Hobbs, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409021/ https://www.ncbi.nlm.nih.gov/pubmed/32708474 http://dx.doi.org/10.3390/cancers12071954 |
Ejemplares similares
-
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment
por: Kjær, Lasse, et al.
Publicado: (2016) -
Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients
por: How, Joan, et al.
Publicado: (2021) -
PB2174: DISSECTING THE MECHANISM OF INTERFERON ALFA (IFNΑ) RESPONSE IN MYELOPROLIFERATIVE NEOPLASM AND IDENTIFICATION OF PREDICTORS OF RESPONSE
por: Soyfer, Eli, et al.
Publicado: (2023) -
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
por: Hasselbalch, Hans Carl, et al.
Publicado: (2018) -
Antibody and T-Cell Responses to COVID-19 Vaccination in Myeloproliferative Neoplasm Patients
por: How, Joan, et al.
Publicado: (2021)